Neuphoria Therapeutics said it expects to receive a milestone payment from Merck for the second clinical trial phase of its Alzheimer's disease dementia treatment.

Milestone payment triggered by the initiation of a Phase 2 clinical trial in Alzheimer’s disease with MK-1167, an α7 ...

Shares of Neuphoria Therapeutics Inc. soared more than 11% in premarket trading on Wednesday, propelling the micro-cap ...

Neuphoria Therapeutics Inc. (Nasdaq: NEUP) (Neuphoria or Company), a late-stage biotechnology developing impactful treatments for neuropsychiatric ...

Neuphoria Therapeutics Inc. (NASDAQ:NEUP) stock soared over 20% following the announcement that the company will receive a ...

The track features... Controversial Danish filmmaker Lars von Trier has been admitted to a care centre for treatment for Parkinson's disease, as reported by his... Whispers of Wes Anderson's ...

Drugs that can prevent or relieve migraine attacks are only effective for some people. Research is starting to untangle the ...

A drug called buprenorphine may be the best tool doctors have to fight the fentanyl crisis. Why hasn’t it been more widely ...

Collagen supplements might make your skin more elastic – but the evidence is weak. Collagen is hugely hyped. This protein, ...

If you're seeking the best weed strains, either for cultivation, pain or relaxation, then these strains of weed should be ...

The disease destroys dopamine-producing cells ... “Anything that’s overly rewarding, anything that induces euphoria or is calming, can be addictive,” says Grant, who runs the Addictive ...

Lavender is a popular choice of when it comes to picking essential oils for sex drive. This is due to its calming properties, ...